omeprazole has been researched along with Adenoma in 12 studies
Omeprazole: A 4-methoxy-3,5-dimethylpyridyl, 5-methoxybenzimidazole derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits an H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS.
omeprazole : A racemate comprising equimolar amounts of (R)- and (S)-omeprazole.
5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole : A member of the class of benzimidazoles that is 1H-benzimidazole which is substituted by a [4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl group at position 2 and a methoxy group at position 5.
Adenoma: A benign epithelial tumor with a glandular organization.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A total of 158 patients (155 early gastric cancers and three adenomas) were randomly assigned to the PPI group (omeprazole 20 mg/day) or H(2) RA group (famotidine 40 mg/day) in a prospective randomized controlled trial." | 5.16 | Prospective randomized controlled trial to compare the effects of omeprazole and famotidine in preventing delayed bleeding and promoting ulcer healing after endoscopic submucosal dissection. ( Fukui, H; Hori, K; Kim, Y; Kondo, T; Matsumoto, T; Miwa, H; Morita, T; Okugawa, T; Oshima, T; Sakurai, J; Tanaka, J; Tomita, T; Toyoshima, F; Watari, J; Yamasaki, T, 2012) |
| "Of 64 patients with an endoscopically diagnosed gastric adenoma and H pylori infection, 32 were treated with omeprazole and antibiotics to eradicate the infection, and 32 were not." | 5.09 | Effect of Helicobacter pylori eradication on malignant transformation of gastric adenoma. ( Arai, K; Kobayashi, R; Mori, M; Ohki, I; Saito, K, 2000) |
| "In our study, oral administration of omeprazole for 1 week was sufficient to achieve healing of ESD-induced artificial gastric ulcers." | 3.81 | Effective healing of endoscopic submucosal dissection-induced ulcers by a single week of proton pump inhibitor treatment: a retrospective study. ( Ando, T; Fujinami, H; Hosokawa, A; Kajiura, S; Mihara, H; Minemura, M; Nishikawa, J; Ogawa, K; Sugiyama, T; Ueda, A, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (8.33) | 18.2507 |
| 2000's | 7 (58.33) | 29.6817 |
| 2010's | 3 (25.00) | 24.3611 |
| 2020's | 1 (8.33) | 2.80 |
| Authors | Studies |
|---|---|
| Madka, V | 1 |
| Kumar, G | 1 |
| Pathuri, G | 1 |
| Panneerselvam, J | 1 |
| Zhang, Y | 1 |
| Ganta, V | 1 |
| Lightfoot, S | 1 |
| Lubet, R | 1 |
| Suen, CS | 1 |
| Steele, VE | 1 |
| Janakiram, NB | 1 |
| Mohammed, A | 1 |
| Rao, CV | 1 |
| Kajiura, S | 1 |
| Hosokawa, A | 1 |
| Ueda, A | 1 |
| Mihara, H | 1 |
| Ando, T | 1 |
| Fujinami, H | 1 |
| Nishikawa, J | 1 |
| Ogawa, K | 1 |
| Minemura, M | 1 |
| Sugiyama, T | 1 |
| Familiar, C | 1 |
| Antón, T | 1 |
| Moraga, I | 1 |
| Ramos, A | 1 |
| Marco, A | 1 |
| Tomita, T | 1 |
| Kim, Y | 1 |
| Yamasaki, T | 1 |
| Okugawa, T | 1 |
| Kondo, T | 1 |
| Toyoshima, F | 1 |
| Sakurai, J | 1 |
| Tanaka, J | 1 |
| Morita, T | 1 |
| Oshima, T | 1 |
| Fukui, H | 1 |
| Hori, K | 1 |
| Watari, J | 1 |
| Matsumoto, T | 1 |
| Miwa, H | 1 |
| Watson, SA | 2 |
| Morris, TM | 1 |
| McWilliams, DF | 1 |
| Harris, J | 1 |
| Evans, S | 1 |
| Smith, A | 1 |
| Clarke, PA | 1 |
| Lee, SY | 1 |
| Kim, JJ | 1 |
| Lee, JH | 1 |
| Kim, YH | 1 |
| Rhee, PL | 1 |
| Paik, SW | 1 |
| Rhee, JC | 1 |
| Kawamura, O | 1 |
| Kusano, M | 1 |
| Shimoyama, Y | 1 |
| Horikoshi, T | 1 |
| Sekiguchi, T | 1 |
| Mori, M | 2 |
| Gotoda, T | 1 |
| Saito, D | 1 |
| Kondo, H | 1 |
| Ono, H | 1 |
| Oda, I | 1 |
| Fujishiro, M | 1 |
| Yamaguchi, H | 1 |
| Saito, K | 1 |
| Arai, K | 1 |
| Kobayashi, R | 1 |
| Ohki, I | 1 |
| Smith, AM | 1 |
| McDonald, JM | 1 |
| Longnecker, DS | 1 |
| Bell, RH | 1 |
| Sato, H | 1 |
| Abe, K | 1 |
| Oshima, N | 1 |
| Kawashima, K | 1 |
| Hamamoto, N | 1 |
| Moritani, M | 1 |
| Mak, R | 1 |
| Ishihara, S | 1 |
| Adachi, K | 1 |
| Kawauchi, H | 1 |
| Kinoshita, Y | 1 |
1 review available for omeprazole and Adenoma
| Article | Year |
|---|---|
[About a case of multiple endocrine neoplasia type 1. Review of some clinical manifestations and treatment controversies].
Topics: Adenoma; Adrenal Gland Neoplasms; Adult; Carcinoid Tumor; Combined Modality Therapy; Duodenal Neopla | 2011 |
4 trials available for omeprazole and Adenoma
| Article | Year |
|---|---|
Prospective randomized controlled trial to compare the effects of omeprazole and famotidine in preventing delayed bleeding and promoting ulcer healing after endoscopic submucosal dissection.
Topics: Adenocarcinoma; Adenoma; Aged; Aged, 80 and over; Analysis of Variance; Famotidine; Female; Gastric | 2012 |
Healing rate of EMR-induced ulcer in relation to the duration of treatment with omeprazole.
Topics: Adenoma; Aged; Anti-Ulcer Agents; Endoscopy, Gastrointestinal; Female; Humans; Male; Omeprazole; Pro | 2004 |
Oral erythromycin accelerates impaired gastrointestinal motility after endoscopic mucosal resection.
Topics: Adenoma; Administration, Oral; Adult; Aged; Dose-Response Relationship, Drug; Endoscopy, Gastrointes | 2007 |
Effect of Helicobacter pylori eradication on malignant transformation of gastric adenoma.
Topics: Adenoma; Aged; Aged, 80 and over; Amoxicillin; Carcinoma; Cell Transformation, Neoplastic; Clarithro | 2000 |
7 other studies available for omeprazole and Adenoma
| Article | Year |
|---|---|
Proton Pump Inhibitor Omeprazole Suppresses Carcinogen-induced Colonic Adenoma Progression to Adenocarcinoma in F344 Rat.
Topics: Adenocarcinoma; Adenoma; Animals; Azoxymethane; Carcinogens; Colonic Neoplasms; Omeprazole; Proton P | 2021 |
Effective healing of endoscopic submucosal dissection-induced ulcers by a single week of proton pump inhibitor treatment: a retrospective study.
Topics: Adenocarcinoma; Adenoma; Aged; Anti-Ulcer Agents; Female; Gastric Mucosa; Gastroscopy; Humans; Male; | 2015 |
Potential role of endocrine gastrin in the colonic adenoma carcinoma sequence.
Topics: Adenocarcinoma; Adenoma; Animals; Colonic Neoplasms; Computer Systems; Enzyme Inhibitors; Female; Fi | 2002 |
Endoscopic and histological reversibility of gastric adenoma after eradication of Helicobacter pylori.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adenoma; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; A | 1999 |
Hypergastrinemia promotes adenoma progression in the APC(Min-/+) mouse model of familial adenomatous polyposis.
Topics: Adenoma; Adenomatous Polyposis Coli; Adenomatous Polyposis Coli Protein; Animals; Bromodeoxyuridine; | 2001 |
Effect of hypergastrinemia on pancreatic carcinogenesis.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adenoma; Animals; Anti-Ulcer Agents; Azaserine; Carcinoma i | 2002 |
Primary hyperparathyroidism with duodenal ulcer and H. pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adenoma; Aged; Anti-Ulcer Agents; Benzimidazoles; Duodenal | 2002 |